等待開盤 10-01 09:30:00 美东时间
+1.020
+1.61%
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从34美元升至35美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.5美元升至7.75美元
09-23 09:52
BWS Financial analyst Hamed Khorsand initiates coverage on John B Sanfilippo & Son (NASDAQ:JBSS) with a Buy rating and announces Price Target of $109.
09-22 21:52
John B Sanfilippo & Son ( ($JBSS) ) has provided an announcement. On August...
08-27 05:00
John B Sanfilippo & Son (NASDAQ:JBSS) reported quarterly earnings of $1.15 per share. This is a 33.72 percent increase over earnings of $0.86 per share from the same period last year. The company reported $269.08
08-21 04:16
Companies Reporting Before The Bell • Futu Holdings (NASDAQ:FUTU) is estimated ...
08-20 16:32
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS), a major processor and distributor of snack and recipe nut products and snack bar manufacturer, will hold its quarterly conference call on Thursday, August 21, 2025, at 10:00 a.m. ET, to discuss its fourth quarter and full-year 2025 operating results, which are expected to be released on August 20, 2025. Registration for the call and webcast access can be found on the company’s website, www.jbssinc.co...
08-13 20:10
John B Sanfilippo & Son ( ($JBSS) ) has issued an update. On August 5, 2025...
08-09 04:46
John B. Sanfilippo & Son (NASDAQ:JBSS) declares $0.90/share annual dividend, Forward yield 1.4% Payable Sept. 11; for shareholders of record Aug. 19; ex-div Aug. 19. The Board of Directors (the “Board...
07-16 04:26
Earnings Call Insights: John B. Sanfilippo & Son, Inc. (JBSS) Q3 2025 Management View CEO Jeffrey Sanfilippo reported a 50% increase in diluted earnings per share despite a decline in sales volume. He...
05-02 02:34
John B Sanfilippo & Son Shares Down 3.8% Premarket After Q2 Results
01-30 18:02